XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
12 Months Ended
Dec. 29, 2022
Nov. 28, 2022
Sep. 08, 2022
Aug. 31, 2022
Aug. 31, 2022
Aug. 15, 2022
Jun. 04, 2021
Dec. 31, 2022
Dec. 31, 2021
Dec. 03, 2021
Subsidiary, Sale of Stock [Line Items]                    
Shares issued       6,081,484 6,081,484   8,522,125      
Shares issued for conversion of debt, value       $ 1,467,000     $ 1,101,846      
Conversion price               $ 0.13    
Interest receivable               $ 134,581 $ 85,685  
Number of common stock issued in exchange of cashless exercise, shares               4,139,503    
Common stock, shares issued               123,252,235 110,840,998  
Common stock, shares outstanding               123,252,235 110,840,998  
Weighted average exercise price               $ 0.48    
Warrants outstanding, aggregate intrinsic value               $ 107,014    
Warrant [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Warrent awarded, shares               492,030    
Warrent awarded               $ 190,335    
Warrent retired, shares               22,000    
Warrent retired               6,763    
Warrants Exercisable, Weighted Average Remaining Contractual Life (Years)               4 years 1 month 6 days    
Warrants outstanding, aggregate intrinsic value               $ 107,014    
Stock Plan 2021 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, shares awarded               716,000    
Average cost per share               $ 0.25    
Share based compensation               $ 178,676    
Stock Plan 2010 [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Common stock, shares awarded               7,704,909    
Average cost per share               $ 0.07    
2010 and 2021 Stock Option [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Share based compensation               $ 557,422    
2010 Stock Option Plan [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Stock options awarded, shares               0 135,000  
Stock options forfieted               144,000    
Stock granted during period value share based compensation                 $ 14,490  
Four Outstanding Warrant [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of common stock issued in exchange of cashless exercise, shares     4,139,503              
Private Placement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued 93,750 156,250       1,400,000        
Shares issued for conversion of debt, value $ 30,000 $ 50,000       $ 600,000        
Conversion price $ 0.32 $ 0.32       $ 0.43        
Joint Venture Agreement [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Number of shares issued,shares                 4,754,552  
Conversion price                   $ 0.2945
Two Convertible Notes [Member] | Two Consultants [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued             930,864      
Shares issued for conversion of debt, value             $ 121,042      
Three Convertible Notes [Member] | Three Officer [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued             7,591,261      
Shares issued for conversion of debt, value             $ 986,864      
Convertible Notes [Member]                    
Subsidiary, Sale of Stock [Line Items]                    
Shares issued       6,081,484            
Shares issued for conversion of debt, value       $ 1,467,000            
Conversion price       $ 0.25 $ 0.25          
Interest receivable       $ 53,371 $ 53,371